Clinical trials: Bioavailability and Pharmacokinetics
Neuroblastoma
Oral Liquid 13-cis-retinoic Acid (13-CRA)
An open label, randomised, multiple dose, cross-over relative bioavailability and pharmacokinetics trial of a novel oral liquid and capsule formulations of 13-CRA administered to patients from 0 months - < 21 years.
- Trial name
- My-CRA (NCT03291080)
- Testing
- Liquid 13-Cis Retinoic Acid, Extracted capsules 13-CRA
- Where
- 10 sites in United Kingdom
- Volunteers
- 20 people
- Sponsor
- Nova Laboratories Limited
Head Lice
A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age
The purpose of this study is to determine the bioavailability of 0.5% ivermectin cream in a pediatric population aged 6 months to 3 years.
- Trial name
- NCT00988533
- Testing
- 0.5% Ivermectin Cream
- Where
- 5 sites in United States
- Volunteers
- 30 people
- Sponsor
- Topaz Pharmaceuticals Inc